National Taiwan Normal University
Taipei, 106, Taiwan
NCT Number: NCT03725189
Aim 1. To explore a novel, non-invasive PPG technology for purposes of monitoring heart rate variability and pulse waveform by harmonic resonance analysis.
Aim 2. To analyze collected data to determine whether it provides useful information about other measures of underlying health.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Taipei, 106, Taiwan
The proposed study will first investigate whether a novel PPG device will be able to measure the harmonic-analysis indexes of the blood pressure waveform (BPWs) to provide information about arterial pulse transmission (by monitoring arterial pulse waveform, Cn) and cardiovascular regulatory activities (by monitoring coefficients of variation, CVn).
Secondarily, data on Cn and CVn could be useful for detecting the arterial elastic properties induced by external stimulation such as exercise, cold stimulation, mental stress, acupuncture, medications such as antihypertensive drugs, or pathological factors such as metabolic syndrome, and breast cancer. The collected data may thus provide information about underlying health.
Photoplethysmography (PPG) is a non-invasive optical technique for evaluating the pulse and hemodynamic changes in frequency. The device obtains a volumetric measurement of an organ via optical illumination (e.g LED). PPG has been used to determine the PaO2, heart rate, and blood pressure (systolic blood pressure, SBP and diastolic blood pressure, DBP) at fingertip and harmonic proportion at fingertip or from the radial artery waveform at the wrist.
However, to the investigator's knowledge, this is the first preliminary study to determine the effects of physical activity on harmonic proportion evaluating by PPG at fingertip. Ultimately, this data may help to develop a non-invasive, external device that could rapidly detect information about cardiovascular and underlying health.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
PPG use for pulse waveform evaluation of healthy exercise group
Time frame: 70 minutes on Day 1 for resting, exercise, and cool down measurements
C1-C10 by PPG device
Time frame: Day 1
Collected from patients by questionnaire
Time frame: Day 1
General health questionnaire
Time frame: Day 1
Weight
Time frame: Day 1
Height
Time frame: Day 1
Body mass index (BMI)
Time frame: 70 minutes on Day 1 for resting, exercise, and cool down measurements
iHealth Feel Wireless blood pressure monitor
Time frame: 70 minutes on Day 1 for resting, exercise, and cool down measurements
iHealth Feel Wireless blood pressure monitor
Time frame: 70 minutes on Day 1 for resting, exercise, and cool down measurements
emWave Pro plus, SDNN indicates standard deviation of normal to normal R-R intervals, where R is the peak of a QRS complex (heartbeat). LF and HF represent power in low- and high-frequency ranges
Time frame: 70 minutes on Day 1 for resting, exercise, and cool down measurements
emWave Pro Plus
University of California, Los Angeles
Other
Pilot Study of the Effect of Physical Activity on Pulse Waveform Monitored by a Novel Photophlethysmographic Device
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details